TrialCancer immunology, immunotherapy : CII2005

A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr).

Ralf G Meyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.